Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom

AIMS: Continuous‐flow left ventricular assist devices (LVADs) as destination therapy (DT) are a recommended treatment by National Institute for Health and Care Excellence England for end‐stage heart failure patients ineligible for cardiac transplantation. Despite the fact that DT is frequently used...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:ESC Heart Fail
Prif Awduron: Schueler, Stephan, Silvestry, Scott C., Cotts, William G., Slaughter, Mark S., Levy, Wayne C., Cheng, Richard K., Beckman, Jennifer A., Villinger, Jonas, Ismyrloglou, Eleni, Tsintzos, Stelios I., Mahr, Claudius
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2021
Pynciau:
Original Research Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8318455/
https://ncbi.nlm.nih.gov/pubmed/34047072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13401
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg